These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15951472)

  • 21. Determination of ciprofloxacin concentrations in human serum and urine by HPLC with ultraviolet and fluorescence detection.
    Sowinski KM; Kays MB
    J Clin Pharm Ther; 2004 Aug; 29(4):381-7. PubMed ID: 15271106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of ciprofloxacin in normal rabbits and changes observed in induced dehydrated state.
    Bashir S; Jamshaid M; Ahmad B; Iqbal J
    Pak J Pharm Sci; 2008 Jul; 21(3):225-9. PubMed ID: 18614416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue penetration of cefpodoxime and cefixime in healthy subjects.
    Liu P; Müller M; Grant M; Obermann B; Derendorf H
    J Clin Pharmacol; 2005 May; 45(5):564-9. PubMed ID: 15831780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients.
    Müller M; Brunner M; Hollenstein U; Joukhadar C; Schmid R; Minar E; Ehringer H; Eichler HG
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2056-8. PubMed ID: 10428936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus).
    Kim MS; Lim JH; Park BK; Hwang YH; Yun HI
    J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
    Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
    J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue penetration of cefpodoxime into the skeletal muscle and lung in rats.
    Liu P; Fuhrherr R; Webb AI; Obermann B; Derendorf H
    Eur J Pharm Sci; 2005; 25(4-5):439-44. PubMed ID: 15905079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.
    Washington C; Hou SY; Hughes NC; Campanella C; Berner B
    J Clin Pharmacol; 2007 Oct; 47(10):1320-6. PubMed ID: 17724088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The disposition kinetics, urinary excretion and dosage regimen of ciprofloxacin in buffalo calves (Bubalus bubalis).
    Saini SP; Srivastava AK
    Vet Res Commun; 2001 Dec; 25(8):641-9. PubMed ID: 11767010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of ciprofloxacin in eels by high-performance liquid chromatography with fluorescence detection.
    Guo L; Xie Z; Lin X; Wu X; Qiu B; Zhang Y; You H; Chen G
    Anal Biochem; 2005 Jun; 341(2):275-9. PubMed ID: 15907873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic interaction of ketoconazole and itraconazole with ciprofloxacin.
    Abou-Auda HS; Mustafa AA; Al-Humayyd MS
    Biopharm Drug Dispos; 2008 Jan; 29(1):29-35. PubMed ID: 17943700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
    Bacracheva N; Scholl H; Gerova Z; Chervenakov P; Dobrev P; Vlahov V
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):352-6. PubMed ID: 1937996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of a once-daily treatment using ciprofloxacin in an extended-release dosage form.
    Schuck EL; Dalhoff A; Stass H; Derendorf H
    Infection; 2005 Dec; 33 Suppl 2():22-8. PubMed ID: 16518708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data.
    Burgess DS; Hall RG
    Clin Ther; 2007 Jul; 29(7):1421-7. PubMed ID: 17825693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-dose pharmacokinetic study of ciprofloxacin and fleroxacin in healthy adult Nigerian volunteers.
    Chukwuani CM; Coker HA; Oduola AM; Ifudu ND; Sowunmi A
    Chemotherapy; 1998; 44(6):369-76. PubMed ID: 9755295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
    Fu LX; Jiang ZG; Ding HZ; Liu YH
    J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penetration of ciprofloxacin into human lung tissue after oral and i.v. dosing.
    Caruso E; Castro JM; Chamoles N; Galimberti R; Jorge L; Rohwedder R
    J Chemother; 1989 Jul; 1(4 Suppl):549-51. PubMed ID: 16312527
    [No Abstract]   [Full Text] [Related]  

  • 38. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung.
    Zeitlinger MA; Traunmüller F; Abrahim A; Müller MR; Erdogan Z; Müller M; Joukhadar C
    Int J Antimicrob Agents; 2007 Jan; 29(1):44-50. PubMed ID: 17189094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.